E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2017 in the Prospect News Structured Products Daily.

New Issue: HSBC prices $2.25 million 10% yield autocallables tied to three stocks

By Susanna Moon

Chicago, June 21 – HSBC USA Inc. priced $2.25 million of 10% autocallable yield notes due June 11, 2018 linked to the common stocks of Amgen, Inc., Biogen Inc. and Thermo Fisher Scientific Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable monthly.

The notes will be called at par if each stock closes at or above its initial level on any review date.

The payout at maturity will be par unless any stock finishes below its 75% trigger level, in which case investors will be fully exposed to any losses of the worst performing stock.

HSBC Securities (USA) Inc. is the agent.

Issuer:HSBC USA Inc.
Issue:Autocallable yield notes
Underlying stocks:Amgen, Inc. (Symbol: AMGN), Biogen Inc. (Symbol: BIIB) and Thermo Fisher Scientific Inc. (Symbol: TMO)
Amount:$2.25 million
Maturity:June 11, 2018
Coupon:10%, payable monthly
Price:Par
Payout at maturity:Par unless any stock falls below 75% trigger, in which case full exposure to any losses of worst performing stock
Call:At par if each index closes at or above initial level on any quarterly review date beginning Sept. 4, 2017
Initial levels:$159.15 for Amgen, $256.65 for Biogen, $176.27 for Thermo Fisher
Barrier levels:$119.3625 for Amgen, $192.4875 for Biogen, $132.2055 for Thermo Fisher; 75% of initial levels
Pricing date:June 2
Settlement date:June 9
Agent:HSBC Securities (USA) Inc.
Fees:1%
Cusip:40435D367

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.